Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""SUBSTANCE abuse"" wg kryterium: Temat


Tytuł:
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma.
Autorzy:
Scaramutti C; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. .
Hervera B; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Rivera Y; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Chueng TA; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Forrest DW; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Suarez E Jr; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Serota DP; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Alkamli H; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Ciraldo K; Department of Family and Community Medicine & Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Bartholomew TS; Division of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Tookes HE; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Feb 23; Vol. 21 (1), pp. 50. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/therapy
Drug Users*
HIV Infections*/complications
HIV Infections*/therapy
Humans ; Health Services Accessibility ; Harm Reduction ; Perceived Discrimination
Czasopismo naukowe
Tytuł:
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
Autorzy:
Lopes SS; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Pericot-Valverde I; Department of Psychology, College of Behavioral, Social, and Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Lum PJ; Department of Medicine, University of California, San Francisco, 1001 Potrero Ave, 94110, San Francisco, CA, USA.
Taylor LE; Department of Pharmacy Practice and Clinical Research, University of Rhode Island, 7 Greenhouse Road, 02881, Kingston, RI, USA.
Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E6546, 21205, Baltimore, MD, USA.
Tsui JI; Department of Medicine, University of Washington, 325 9th Ave, 98104, Seattle, WA, USA.
Feinberg J; Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, 930 Chestnut Ridge Road, 26505, Morgantown, WV, USA.; Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, 1 Medical Center Drive, 26506, Morgantown, WV, USA.
Kim AY; Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit St, 02114, Boston, MA, USA.; Harvard Medical School, 02115, Boston, MA, USA.
Norton BL; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Page K; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Murray-Krezan C; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, 15213, Pittsburgh, PA, USA.
Anderson J; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Karasz A; UMass Chan Medical School, University of Massachusetts Medical School, 55 Lake Ave, North, 01605, Worcester, MA, USA.
Arnsten J; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Moschella P; Department of Emergency Medicine, Prisma Health, Greenville, SC, USA.; School of Health Research, Clemson University, Clemson, SC, USA.; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA.
Heo M; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Litwin AH; School of Health Research, Clemson University, Clemson, SC, USA. .; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA. .; Department of Medicine, Prisma Health, 29605, Greenville, SC, USA. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 251. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Users*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/drug therapy
Hepatitis C*/complications
Humans ; Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Sustained Virologic Response
Czasopismo naukowe
Tytuł:
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).
Autorzy:
Goodman-Meza D; Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave., CHS 52-215, Los Angeles, CA, 90095-1688, USA. .
Shoptaw S; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Hanscom B; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Seattle, WA, USA.
Smith LR; Division of Infectious Diseases and Global Public Health, University of California, San Diego, San Diego, CA, USA.
Andrew P; Family Health International (FHI 360), Durham, NC, USA.
Kuo I; Milken Institute School of Public Health Department of Epidemiology, George Washington University, Washington, DC, USA.
Lake JE; UTHealth-Houston, Houston, TX, USA.
Metzger D; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Morrison EAB; ICAP, Mailman School of Public Health, Columbia University, New York, NY, USA.
Cummings M; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Fogel JM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Richardson P; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Harris J; Family Health International (FHI 360), Durham, NC, USA.
Heitner J; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Stansfield S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
El-Bassel N; School of Social Work, Columbia University, New York, NY, USA.
Pokaż więcej
Corporate Authors:
HPTN 094 Study Team
Źródło:
Trials [Trials] 2024 Feb 15; Vol. 25 (1), pp. 124. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/complications
Drug Users*
HIV Infections*/diagnosis
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Sexually Transmitted Diseases*/diagnosis
Sexually Transmitted Diseases*/epidemiology
Sexually Transmitted Diseases*/prevention & control
Opioid-Related Disorders*/diagnosis
Opioid-Related Disorders*/epidemiology
Opioid-Related Disorders*/prevention & control
Humans ; Pharmaceutical Preparations ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder.
Autorzy:
Marks LR; Division of Infectious Disease, Washington University School of Medicine, Campus Box 8051, 4523 Clayton Avenue, St. Louis, MO, USA. .
Durkin MJ; Division of Infectious Disease, Washington University School of Medicine, Campus Box 8051, 4523 Clayton Avenue, St. Louis, MO, USA.
Ayres K; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Ellis M; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Jan 19; Vol. 21 (1), pp. 16. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Opioid-Related Disorders*/epidemiology
Opioid-Related Disorders*/complications
HIV Infections*/complications
Humans ; Needle-Exchange Programs ; Harm Reduction ; Abscess ; Drug Compounding
Czasopismo naukowe
Tytuł:
Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol.
Autorzy:
Klaman SL; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Godino JG; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA. .
Northrup A; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Lewis SV; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Tam A; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Carrillo C; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Lewis R; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Matthews E; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Mendez B; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Reyes L; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Rojas S; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Ramers C; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 19; Vol. 24 (1), pp. 105. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Drug Users*
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Adult ; Humans ; Hepacivirus ; Antiviral Agents/therapeutic use ; Prospective Studies ; Quality Improvement ; Seroepidemiologic Studies ; Algorithms ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
People Who Inject Drugs in Mozambique: We need to normalize HIV treatment and care services in specialized community centers for people who inject drugs!
Autorzy:
Semá Baltazar C; National Institute of Health, P.O. Box 264, Maputo, Mozambique. .
Ribeiro Banze A; National Institute of Health, P.O. Box 264, Maputo, Mozambique.
Seleme J; Mozambique National Program for STI, HIV and AIDS Control, Ministry Oh Health, Maputo, Mozambique.
Boothe M; UNAIDS, Maputo, Mozambique.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Jan 06; Vol. 21 (1), pp. 6. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Letter
MeSH Terms:
Drug Users*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/therapy
Epidemics*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Humans ; Mozambique
Opinia redakcyjna
Tytuł:
WaSH insecurity and anxiety among people who inject drugs in the Tijuana-San Diego border region.
Autorzy:
Portillo LJA; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA. .; Benioff Homelessness and Housing Initiative, School of Medicine, University of California San Francisco, San Francisco, CA, USA. .
Calderón-Villarreal A; Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA.; School of Public Health, San Diego State University, San Diego, CA, USA.
Abramovitz D; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Harvey-Vera A; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.; Facultad de Medicina, Campus Tijuana, Universidad de Xochicalco, Tijuana, Baja California, México.; United States-Mexico Border Health Commission, Tijuana, Baja California, Mexico.
Cassels S; Department of Geography, University of California Santa Barbara, Santa Barbara, CA, USA.
Vera CF; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Munoz S; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Tornez A; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Rangel G; United States-Mexico Border Health Commission, Tijuana, Baja California, Mexico.; Departamento de Estudios de Población, Colegio de La Frontera Norte, Tijuana, México.
Strathdee SA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.
Kayser GL; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Jan 02; Vol. 24 (1), pp. 19. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/complications
Drug Users*
Drinking Water*
Humans ; Male ; Female ; Sanitation ; Cross-Sectional Studies ; Anxiety/epidemiology ; Anxiety Disorders/complications ; Hygiene
Czasopismo naukowe
Tytuł:
Acceptance and feasibility of a low-threshold and substitution services-based periodical monitoring system for blood-borne and sexually transmitted infections among people who inject drugs in Germany: a mixed-methods analysis.
Autorzy:
Krings A; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany. .
Steffen G; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.
Zimmermann R; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.
Pokaż więcej
Corporate Authors:
DRUCK 2.0-study group
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Mar 14; Vol. 21 (1), pp. 62. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/drug therapy
Drug Users*
Sexually Transmitted Diseases*
HIV Infections*/prevention & control
Hepatitis C*/epidemiology
Humans ; Feasibility Studies ; Pilot Projects
Czasopismo naukowe
Tytuł:
The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.
Autorzy:
Morgan B; Department of Medicine, Monash Health, Clayton, Australia. .
Lancaster R; Addiction Medicine Unit, Monash Health, Clayton, Australia.
Boyagoda B; Central Clinical School, Monash University, Clayton, Australia.
Ananda R; Department of Medicine, Monash Health, Clayton, Australia.
Attwood LO; Central Clinical School, Monash University, Clayton, Australia.; Department of Infectious Diseases, Alfred Health, Clayton, Australia.; Monash Infectious Diseases, Monash Health, Clayton, Australia.
Jacka D; Addiction Medicine Unit, Monash Health, Clayton, Australia.
Woolley I; Central Clinical School, Monash University, Clayton, Australia. .; Department of Infectious Diseases, Alfred Health, Clayton, Australia. .; Monash Infectious Diseases, Monash Health, Clayton, Australia. .; School of Clinical Sciences, Monash University, Clayton, Australia. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 07; Vol. 24 (1), pp. 299. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Drug Users*
Hepatitis C*
Soft Tissue Infections*/epidemiology
Arthritis, Infectious*
Adult ; Humans ; Male ; Female ; Retrospective Studies ; Bone and Bones ; Victoria
Czasopismo naukowe
Tytuł:
"No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
Autorzy:
Walker S; National Drug Research Institute, Curtin University, Perth, Western Australia, Australia. .; Burnet Institute, Melbourne, Victoria, Australia. .; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. .
Curtis M; National Drug Research Institute, Curtin University, Perth, Western Australia, Australia.; Burnet Institute, Melbourne, Victoria, Australia.
Kirwan A; Burnet Institute, Melbourne, Victoria, Australia.
Thatcher R; Access Health & 24/7 Needle and Syringe Program, Alcohol, Drugs and Other Addictions Stream, Victoria Social Mission Department, The Salvation Army Australian Territory, Melbourne, Victoria, Australia.
Dietze P; National Drug Research Institute, Curtin University, Perth, Western Australia, Australia.; Burnet Institute, Melbourne, Victoria, Australia.; Monash Addiction Research Centre, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Feb 24; Vol. 21 (1), pp. 51. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*
Illicit Drugs*
Humans ; Female ; Needle-Exchange Programs/methods ; Needles ; Victoria ; Naloxone/therapeutic use
Czasopismo naukowe
Tytuł:
Come back when you're infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023.
Autorzy:
Russell DM; Arizona State University, Tempe, AZ, USA.; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.
Meyerson BE; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA. .; Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA. .; Center for Comprehensive Pain and Addiction, University of Arizona Health Sciences, Tucson, AZ, USA. .
Mahoney AN; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Southwest Recovery Alliance, Phoenix, AZ, USA.; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.
Garnett I; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.; Center for Comprehensive Pain and Addiction, University of Arizona Health Sciences, Tucson, AZ, USA.
Ferrell C; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.; CAN Community Health, Phoenix, AZ, USA.
Newgass K; Southwest Recovery Alliance, Phoenix, AZ, USA.; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.
Agley JD; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.
Crosby RA; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; University of Kentucky College of Public Health, Lexington, KY, USA.
Bentele KG; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Southwest Institute for Research On Women, University of Arizona, Tucson, AZ, USA.
Vadiei N; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Frank D; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; School of Global Public Health, New York University, New York, USA.
Linde-Krieger LB; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Feb 22; Vol. 21 (1), pp. 49. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Pharmacies*
HIV Infections*/prevention & control
Substance Abuse, Intravenous*
Pharmacy*
Humans ; Syringes ; Arizona
Czasopismo naukowe
Tytuł:
Loneliness and fearfulness are associated with non-fatal drug overdose among people who inject drugs.
Autorzy:
Falade-Nwulia O; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Ward K; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; School of Public Health, Drexel University, Philadelphia, PA, United States of America.
Wagner KD; School of Public Health, University of Nevada, Reno, NV, United States of America.
Karimi-Sari H; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Hsu J; Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Sulkowski M; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Latkin C; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Nwulia E; Department of Psychiatry, Howard University, Washington, DC, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 21; Vol. 19 (2), pp. e0297209. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Drug Users*
Drug Overdose*/epidemiology
Drug Overdose*/psychology
Humans ; Female ; Adult ; Middle Aged ; Male ; Loneliness ; Cross-Sectional Studies
Czasopismo naukowe
Tytuł:
Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital.
Autorzy:
Brooks HL; School of Public Health, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Speed KA; School of Public Health, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Dong K; Department of Emergency Medicine, Faculty of Medicine & Dentistry, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Salvalaggio G; Department of Family Medicine, Faculty of Medicine & Dentistry, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Pauly BB; Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.
Taylor M; Streetworks, Boyle Street Community Services, Edmonton, Alberta, Canada.
Hyshka E; School of Public Health, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 15; Vol. 19 (2), pp. e0297584. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Humans ; Needle-Exchange Programs ; Needles ; Inpatients ; Policy
Czasopismo naukowe
Tytuł:
Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge.
Autorzy:
Bromberg DJ; Yale School of Public Health, Yale University, New Haven, Connecticut, USA.; Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, USA.; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Machavariani E; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Madden LM; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.; APT Foundation, New Haven, Connecticut, USA.
Dumchev K; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
LaMonaca K; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Earnshaw VA; University of Delaware, Newark, Delaware, USA.
Pykalo I; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Filippovych M; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Haddad MS; Center for Key Populations, Community Health Center, Inc., Middletown, Connecticut, USA.
Dvoriak S; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Altice FL; Yale School of Public Health, Yale University, New Haven, Connecticut, USA.; Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, USA.; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.; University of Delaware, Newark, Delaware, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26202.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
HIV Infections*/drug therapy
HIV Infections*/prevention & control
HIV Infections*/complications
Humans ; Methadone/therapeutic use ; Analgesics, Opioid/therapeutic use ; Ukraine ; Primary Health Care
Czasopismo naukowe
Tytuł:
Late Recurrence of Prosthetic Valve Endocarditis Due to Candida albicans.
Autorzy:
Al-Hashimi I; Office of Graduate Medical Education, University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Qazi M; Department of Medicine, University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Hickerson S; East Texas Infectious Disease Consultants, UT Health East Texas, Tyler, TX, USA.
Okon E; Department of Infectious Diseases, Christus Trinity Clinic, Tyler, TX, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Feb 01; Vol. 25, pp. e942399. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Endocarditis, Bacterial*/drug therapy
Substance Abuse, Intravenous*
Heart Valve Prosthesis*/adverse effects
Heart Valve Prosthesis*/microbiology
Endocarditis*/microbiology
Candidiasis*/diagnosis
Candidiasis*/drug therapy
Heart Valve Diseases*/etiology
Female ; Humans ; Adult ; Candida albicans ; Fluconazole/therapeutic use ; Micafungin/therapeutic use
Czasopismo naukowe
Tytuł:
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego-Tijuana border region.
Autorzy:
Pines HA; Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, CA, USA. .; Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla, CA, USA. .; Department of Medicine, University of California, San Diego, La Jolla, CA, USA. .
Eger WH; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.; School of Social Work, San Diego State University, San Diego, CA, USA.
Skaathun B; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Vera CF; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Harvey-Vera A; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Rangel G; Mexico Section of the US-Mexico Border Health Commission, Tijuana, Baja California, Mexico.; El Colegio de la Frontera Norte, Tijuana, Baja California, Mexico.
Strathdee SA; Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Bazzi AR; Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla, CA, USA.; School of Public Health, Boston University, Boston, MA, USA.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2024 Jan 03; Vol. 21 (1), pp. 4. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/epidemiology
HIV Infections*/diagnosis
HIV Infections*/epidemiology
Drug Users*
Humans ; Self-Testing ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Funding and Delivery of Syringe Services Programs in the United States, 2022.
Autorzy:
Facente SN; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Humphrey JL; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Akiba C; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Patel SV; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Wenger LD; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Tookes H; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Bluthenthal RN; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
LaKosky P; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Prohaska S; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Morris T; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Kral AH; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Lambdin BH; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Pokaż więcej
Źródło:
American journal of public health [Am J Public Health] 2024 Apr; Vol. 114 (4), pp. 435-443.
Typ publikacji:
Journal Article
MeSH Terms:
Needle-Exchange Programs*
Substance Abuse, Intravenous*
United States ; Humans ; Naloxone ; Benchmarking ; Public Health
Czasopismo naukowe
Tytuł:
Models of good practice to enhance infectious disease care cascades among people who inject drugs: a qualitative study of interventions implemented in European settings.
Autorzy:
Horváth I; Austrian National Public Health Institute (Gesundheit Österreich GmbH, GOEG), Vienna, Austria. .
Mårdh O; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Schwarz T; Austrian National Public Health Institute (Gesundheit Österreich GmbH, GOEG), Vienna, Austria.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Dec 04; Vol. 23 (1), pp. 1352. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Acquired Immunodeficiency Syndrome*
Drug Users*
Communicable Diseases*
Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Tuberculosis*/prevention & control
Hepatitis C*/epidemiology
Hepatitis C*/prevention & control
Humans
Czasopismo naukowe
Tytuł:
A single site study to investigate the current prevalence of anti-hepatitis C virus antibody among substance use disorder patients in Hiroshima-Insufficient testing and diagnosis.
Autorzy:
Kagaya A; KONUMA Memorial Institute of Addiction and Mental Health, Hiroshima, Japan.
Nagaoki Y; Department of Gastroenterology, Mazda Hospital, Mazda Motor Corporation, Hiroshima, Japan.
Shimura S; AbbVie GK, Tokyo, Japan.
Kawana K; AbbVie GK, Tokyo, Japan.
Chayama K; Department of Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2023 Dec; Vol. 43 (4), pp. 521-531. Date of Electronic Publication: 2023 May 16.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Hepatitis C*/drug therapy
Substance-Related Disorders*/diagnosis
Substance-Related Disorders*/epidemiology
Substance-Related Disorders*/complications
Humans ; Prevalence ; Hepatitis C Antibodies/therapeutic use ; Seroepidemiologic Studies ; Hepacivirus
Czasopismo naukowe
Tytuł:
Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study.
Autorzy:
Mehmandoost S; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Mirzazadeh A; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Karamouzian M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Khezri M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Department of Epidemiology, New York University School of Global Public Health, New York, NY, USA.
Sharafi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Shahesmaeili A; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Maghsoudi SH; Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Ghalekhani N; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Tavakoli F; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Bazrafshani MS; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Shokoohi M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Aghaali N; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Haghdoost AA; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Sharifi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. .
Pokaż więcej
Źródło:
Substance abuse treatment, prevention, and policy [Subst Abuse Treat Prev Policy] 2023 Nov 29; Vol. 18 (1), pp. 72. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/complications
Drug Users*
Hepatitis C*/epidemiology
Hepatitis C*/complications
Humans ; Female ; Iran/epidemiology ; Cohort Studies ; Hepacivirus ; Recurrence ; Prevalence
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies